Literature DB >> 23558029

MRI-compatible pipeline for three-dimensional MALDI imaging mass spectrometry using PAXgene fixation.

Janina Oetjen1, Michaela Aichler, Dennis Trede, Jan Strehlow, Judith Berger, Stefan Heldmann, Michael Becker, Michael Gottschalk, Jan Hendrik Kobarg, Stefan Wirtz, Stefan Schiffler, Herbert Thiele, Axel Walch, Peter Maass, Theodore Alexandrov.   

Abstract

MALDI imaging mass spectrometry (MALDI-imaging) has emerged as a spatially-resolved label-free bioanalytical technique for direct analysis of biological samples and was recently introduced for analysis of 3D tissue specimens. We present a new experimental and computational pipeline for molecular analysis of tissue specimens which integrates 3D MALDI-imaging, magnetic resonance imaging (MRI), and histological staining and microscopy, and evaluate the pipeline by applying it to analysis of a mouse kidney. To ensure sample integrity and reproducible sectioning, we utilized the PAXgene fixation and paraffin embedding and proved its compatibility with MRI. Altogether, 122 serial sections of the kidney were analyzed using MALDI-imaging, resulting in a 3D dataset of 200GB comprised of 2million spectra. We show that elastic image registration better compensates for local distortions of tissue sections. The computational analysis of 3D MALDI-imaging data was performed using our spatial segmentation pipeline which determines regions of distinct molecular composition and finds m/z-values co-localized with these regions. For facilitated interpretation of 3D distribution of ions, we evaluated isosurfaces providing simplified visualization. We present the data in a multimodal fashion combining 3D MALDI-imaging with the MRI volume rendering and with light microscopic images of histologically stained sections. BIOLOGICAL SIGNIFICANCE: Our novel experimental and computational pipeline for 3D MALDI-imaging can be applied to address clinical questions such as proteomic analysis of the tumor morphologic heterogeneity. Examining the protein distribution as well as the drug distribution throughout an entire tumor using our pipeline will facilitate understanding of the molecular mechanisms of carcinogenesis.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  3D MALDI imaging mass spectrometry; 3D spatial segmentation; Histology; MRI; Mouse kidney; PAXgene fixation

Mesh:

Substances:

Year:  2013        PMID: 23558029     DOI: 10.1016/j.jprot.2013.03.013

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  19 in total

1.  Automatic 3D Nonlinear Registration of Mass Spectrometry Imaging and Magnetic Resonance Imaging Data.

Authors:  Walid M Abdelmoula; Michael S Regan; Begona G C Lopez; Elizabeth C Randall; Sean Lawler; Ann C Mladek; Michal O Nowicki; Bianca M Marin; Jeffrey N Agar; Kristin R Swanson; Tina Kapur; Jann N Sarkaria; William Wells; Nathalie Y R Agar
Journal:  Anal Chem       Date:  2019-04-22       Impact factor: 6.986

2.  Evaluation of colon cancer histomorphology: a comparison between formalin and PAXgene tissue fixation by an international ring trial.

Authors:  Sibylle Gündisch; Julia Slotta-Huspenina; Paolo Verderio; Chiara Maura Ciniselli; Sara Pizzamiglio; Christina Schott; Enken Drecoll; Christian Viertler; Kurt Zatloukal; Marcel Kap; Peter Riegman; Irene Esposito; Katja Specht; Gregor Babaryka; Martin Asslaber; Koppany Bodó; Michael den Bakker; Jan den Hollander; Falko Fend; Jens Neumann; Simone Reu; Aurel Perren; Rupert Langer; Alessandro Lugli; Ingrid Becker; Thomas Richter; Gian Kayser; Annette M May; Fatima Carneiro; José Manuel Lopes; Leslie Sobin; Heinz Höfler; Karl-Friedrich Becker
Journal:  Virchows Arch       Date:  2014-08-02       Impact factor: 4.064

3.  Three-Dimensional Imaging with Infrared Matrix-Assisted Laser Desorption Electrospray Ionization Mass Spectrometry.

Authors:  Hongxia Bai; Sitora Khodjaniyazova; Kenneth P Garrard; David C Muddiman
Journal:  J Am Soc Mass Spectrom       Date:  2019-12-30       Impact factor: 3.109

4.  Spatial Metabolomics and Imaging Mass Spectrometry in the Age of Artificial Intelligence.

Authors:  Theodore Alexandrov
Journal:  Annu Rev Biomed Data Sci       Date:  2020-04-13

Review 5.  Dual-Mode Tumor Imaging Using Probes That Are Responsive to Hypoxia-Induced Pathological Conditions.

Authors:  S A Amali S Subasinghe; Robia G Pautler; Md Abul Hassan Samee; Jason T Yustein; Matthew J Allen
Journal:  Biosensors (Basel)       Date:  2022-06-30

6.  Discovering New Lipidomic Features Using Cell Type Specific Fluorophore Expression to Provide Spatial and Biological Specificity in a Multimodal Workflow with MALDI Imaging Mass Spectrometry.

Authors:  Marissa A Jones; Sung Hoon Cho; Nathan Heath Patterson; Raf Van de Plas; Jeffrey M Spraggins; Mark R Boothby; Richard M Caprioli
Journal:  Anal Chem       Date:  2020-05-06       Impact factor: 6.986

7.  Advanced mass spectrometry technologies for the study of microbial pathogenesis.

Authors:  Jessica L Moore; Richard M Caprioli; Eric P Skaar
Journal:  Curr Opin Microbiol       Date:  2014-07-03       Impact factor: 7.934

Review 8.  Mass Spectrometry Imaging: A Review of Emerging Advancements and Future Insights.

Authors:  Amanda Rae Buchberger; Kellen DeLaney; Jillian Johnson; Lingjun Li
Journal:  Anal Chem       Date:  2017-12-13       Impact factor: 6.986

9.  MALDI imaging mass spectrometry of N-linked glycans on formalin-fixed paraffin-embedded murine kidney.

Authors:  Ove J R Gustafsson; Matthew T Briggs; Mark R Condina; Lyron J Winderbaum; Matthias Pelzing; Shaun R McColl; Arun V Everest-Dass; Nicolle H Packer; Peter Hoffmann
Journal:  Anal Bioanal Chem       Date:  2014-12-02       Impact factor: 4.142

Review 10.  Predictive Markers of Immunogenicity and Efficacy for Human Vaccines.

Authors:  Matthieu Van Tilbeurgh; Katia Lemdani; Anne-Sophie Beignon; Catherine Chapon; Nicolas Tchitchek; Lina Cheraitia; Ernesto Marcos Lopez; Quentin Pascal; Roger Le Grand; Pauline Maisonnasse; Caroline Manet
Journal:  Vaccines (Basel)       Date:  2021-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.